title: Corneal response to canakinumab in cryopyrin associated periodic fever syndrome.
authors.forename: M
authors.initials: M
authors.lastname: Tsatsos
authors.forename: P N
authors.initials: PN
authors.lastname: Hawkin
authors.forename: P
authors.initials: P
authors.lastname: Hossain
mesh_terms: D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002352:Carrier Proteins / Q000235:genetics; D003316:Corneal Diseases / Q000188:drug therapy* / Q000235:genetics; D056587:Cryopyrin-Associated Periodic Syndromes / Q000188:drug therapy* / Q000235:genetics; D005091:Exons / Q000235:genetics; D005260:Female; D006801:Humans; D053583:Interleukin-1beta / Q000037:antagonists & inhibitors*; D008297:Male; D009154:Mutation; D000071199:NLR Family, Pyrin Domain-Containing 3 Protein; D016896:Treatment Outcome; D014786:Vision Disorders / Q000188:drug therapy; D014792:Visual Acuity / Q000187:drug effects
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D002352:Carrier Proteins; D053583:Interleukin-1beta; D000071199:NLR Family, Pyrin Domain-Containing 3 Protein; C453881:NLRP3 protein, human; C541220:canakinumab
keywords: Cornea; Drugs; Immunology; Inflammation; Treatment Medical